Neumann, H. P. H., Erlic, Z., Boedeker, C. C., Rybicki, L. A., Robledo, M., Hermsen, M., . . . Eng, C. (2009). Clinical predictors for germline mutations in head and neck paraganglioma patients: Cost reduction strategy in genetic diagnostic process as Fall-Out. Cancer research, 69(8), . https://doi.org/10.1158/0008-5472.CAN-08-4057
Chicago Style (17th ed.) CitationNeumann, Hartmut P. H., et al. "Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out." Cancer Research 69, no. 8 (2009). https://doi.org/10.1158/0008-5472.CAN-08-4057.
MLA (9th ed.) CitationNeumann, Hartmut P. H., et al. "Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out." Cancer Research, vol. 69, no. 8, 2009, https://doi.org/10.1158/0008-5472.CAN-08-4057.